Federal Court Overturns Gilead Sciences and Merck Patent Dispute Post author:Sam Post published:February 19, 2018 Post category:BioPharma Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace You Might Also Like GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017 FDA Slaps Clinical Hold on Concert Pharma's Hair Loss Drug May 16, 2017 <b>Saintyco</b> Introduces Portable Mini Fluid Bed Granulator And Coater For Labs & R&D June 5, 2017
GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017